We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > LISCure Biosciences

News List

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases prnasia
January 07, 2022
LISCure Biosciences Inc., a leading biotech focused on microbial-based therapeutics, announced that it has executed a research collaboration agreement with Mayo Clinic for new drug development for rare liver diseases.
LISCure Biosciences completes seed funding of $5M biospectrumasia
July 28, 2019
Furthermore, a series of studies published recently suggested that the treatment rate of immunosuppressants is affected by the intestinal microbiological environment. Microbiomes have emerged as a means that can improve the low response rate of immunosupp